COMMODORE CAPITAL LP
data from 30/09/2025
Capitalization
$ 2.048 B
44.59 %
Performance
$ 791.333 M
87.44 %
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2025/09/30 | MRUS | MERUS N V | 16.20% | 331.879 M $ | 3525000 | 2021/09/30 | 146.464 M $ | 78.99 % |
| 2025/09/30 | NUVL | NUVALENT INC | 5.91% | 121.072 M $ | 1400000 | 2022/12/31 | 13.998 M $ | 13.34 % |
| 2025/09/30 | XENE | XENON PHARMACEUTICALS INC | 5.29% | 108.405 M $ | 2700000 | 2020/12/31 | 26.771 M $ | 28.27 % |
| 2025/09/30 | COGT | COGENT BIOSCIENCES INC | 5.08% | 104.110 M $ | 7250000 | 2020/12/31 | 16.594 M $ | 100.00 % |
| 2025/09/30 | ELVN | ENLIVEN THERAPEUTICS INC | 4.69% | 96.062 M $ | 4692809 | 2023/03/31 | 1.924 M $ | 2.04 % |
| 2025/09/30 | AGIO | AGIOS PHARMACEUTICALS INC | 4.58% | 93.859 M $ | 2338287 | 2025/03/31 | 15.996 M $ | 20.69 % |
| 2025/09/30 | ALKS | ALKERMES PLC | 4.54% | 92.903 M $ | 3096754 | 2024/06/30 | 3.406 M $ | 4.86 % |
| 2025/09/30 | SLNO | SOLENO THERAPEUTICS INC | 4.46% | 91.260 M $ | 1350000 | 2023/09/30 | -9.870 M $ | -19.31 % |
| 2025/09/30 | RLAY | RELAY THERAPEUTICS INC | 4.33% | 88.740 M $ | 17000000 | 2025/06/30 | 23.496 M $ | 50.87 % |
| 2025/09/30 | CLDX | CELLDEX THERAPEUTICS INC NEW | 3.82% | 78.343 M $ | 3028335 | 2020/12/31 | 19.044 M $ | 27.13 % |
| 2025/09/30 | CNTA | CENTESSA PHARMACEUTICALS PLC | 3.37% | 69.113 M $ | 2850000 | 2024/09/30 | 36.644 M $ | 84.55 % |
| 2025/09/30 | VRDN | VIRIDIAN THERAPEUTICS INC | 3.37% | 69.056 M $ | 3200000 | 2021/03/31 | 37.050 M $ | 54.36 % |
| 2025/09/30 | PTGX | PROTAGONIST THERAPEUTICS INC | 3.32% | 68.091 M $ | 1025000 | 2025/06/30 | 11.997 M $ | 20.19 % |
| 2025/09/30 | PHVS | PHARVARIS N V | 2.95% | 60.341 M $ | 2418476 | 2023/12/31 | 14.049 M $ | 41.76 % |
| 2025/09/30 | CDTX | CIDARA THERAPEUTICS INC | 2.73% | 56.020 M $ | 585000 | 2025/06/30 | 55.284 M $ | 96.59 % |
| 2025/09/30 | AMLX | AMYLYX PHARMACEUTICALS INC | 2.70% | 55.386 M $ | 4075478 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | TYRA | TYRA BIOSCIENCES INC | 2.31% | 47.216 M $ | 3375000 | 2025/03/31 | 13.702 M $ | 46.19 % |
| 2025/09/30 | TERN | TERNS PHARMACEUTICALS INC | 2.09% | 42.807 M $ | 5700000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | KYMR | KYMERA THERAPEUTICS INC | 2.07% | 42.450 M $ | 750000 | 2025/06/30 | 9.720 M $ | 29.70 % |
| 2025/09/30 | MNMD | MIND MEDICINE MINDMED INC | 1.86% | 38.023 M $ | 3225000 | 2024/03/31 | 26.500 M $ | 81.66 % |
| 2025/09/30 | NRIX | NURIX THERAPEUTICS INC | 1.71% | 34.928 M $ | 3780055 | 2024/09/30 | -8.490 M $ | -18.88 % |
| 2025/09/30 | ORKA | ORUKA THERAPEUTICS INC | 1.65% | 33.711 M $ | 1753054 | 2024/09/30 | 11.386 M $ | 71.54 % |
| 2025/09/30 | SYRE | SPYRE THERAPEUTICS INC | 1.63% | 33.320 M $ | 1988084 | 2023/09/30 | 3.559 M $ | 11.96 % |
| 2025/09/30 | DRUG | BRIGHT MINDS BIOSCIENCES INC | 1.48% | 30.330 M $ | 500000 | 2024/12/31 | 17.275 M $ | 132.32 % |
| 2025/09/30 | ASMB | ASSEMBLY BIOSCIENCES INC | 1.25% | 25.600 M $ | 1000000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | CTMX | CYTOMX THERAPEUTICS INC | 1.20% | 24.538 M $ | 7692300 | 2025/06/30 | 7.077 M $ | 40.53 % |
| 2025/09/30 | LBRX | LB PHARMACEUTICALS INC | 1.16% | 23.685 M $ | 1500000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | TNGX | TANGO THERAPEUTICS INC | 0.62% | 12.600 M $ | 1500000 | 2025/06/30 | 4.920 M $ | 64.06 % |
| 2025/09/30 | APGE | APOGEE THERAPEUTICS INC | 0.56% | 11.522 M $ | 290000 | 2023/09/30 | -1.073 M $ | -8.52 % |
| 2025/09/30 | PEPG | PEPGEN INC | 0.53% | 10.891 M $ | 2357319 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | ENTA | ENANTA PHARMACEUTICALS INC | 0.47% | 9.576 M $ | 800000 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | SABS | SAB BIOTHERAPEUTICS INC | 0.43% | 8.847 M $ | 4401500 | 2025/09/30 | 0.000 $ | 0.00 % |
| 2025/09/30 | IKT | INHIBIKASE THERAPEUTICS INC | 0.43% | 8.744 M $ | 5397488 | 2024/12/31 | -1.781 M $ | -16.92 % |
| 2025/09/30 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | 0.39% | 7.920 M $ | 750000 | 2024/06/30 | -14.999 K $ | -0.19 % |
| 2025/09/30 | AVTX | AVALO THERAPEUTICS INC | 0.30% | 6.139 M $ | 483000 | 2024/06/30 | 3.729 M $ | 154.71 % |
| 2025/09/30 | VTGN | VISTAGEN THERAPEUTICS INC | 0.27% | 5.591 M $ | 1575000 | 2023/09/30 | 2.441 M $ | 77.50 % |
| 2025/09/30 | CBIO | CRESCENT BIOPHARMA INC. | 0.26% | 5.360 M $ | 450829 | 2025/06/30 | -1.928 M $ | -26.33 % |
| 2025/09/30 | VERA | VERA THERAPEUTICS INC | 0.00% | 0.000 $ | 0 | 2023/03/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | NGNE | NEUROGENE INC | 0.00% | 0.000 $ | 0 | 2024/03/31 | 0.000 $ | 0.00 % |
| 2025/09/30 | SRRK | SCHOLAR ROCK HLDG CORP | 0.00% | 0.000 $ | 0 | 2024/12/31 | 0.000 $ | 0.00 % |